MEDIUM confidence
Researched 2026-07-22 22:42 · profile: researcher
Programme Thesis
The DoD Vision Translational Research Award funds early-stage, high-risk translational research that addresses critical military and defense health needs, with a focus on developing novel therapeutics, diagnostics, or technologies that can be rapidly transitioned to clinical or operational use. It exists to bridge the gap between basic discovery and deployable solutions for warfighter health, including addiction and brain health.
Selection Criteria
Scientific merit and innovation (40%) – novelty, feasibility, and potential impact; Relevance to defense health (30%) – clear connection to military readiness, addiction, or brain injury; Investigator qualifications and resources (20%) – expertise, track record, and institutional support; Budget and project management (10%) – realistic budget, clear milestones, and transition plan.
Past Winners / Cohort Profiles
Past winners typically include early-career to mid-career researchers at US universities or small businesses, often with prior DoD funding or collaborations. Examples include projects on PTSD biomarkers, traumatic brain injury diagnostics, and opioid addiction interventions. No specific named winners were found on the page, but the archetype is a PI with a strong translational plan and a clear path to military application.
Ideal Candidate Fingerprint
The ideal applicant is a US-based early-career researcher (postdoc or junior faculty) with a strong publication record in neuroscience or pharmacology, a clear translational hypothesis, and a well-defined plan for moving from bench to bedside. They have preliminary data, a provisional patent or IP strategy, and letters of support from military or clinical collaborators.
Recommended Framing
Eniola should frame the CCT model as a novel, patent-protected pharmacological framework for preventing reward-memory consolidation in addiction, directly addressing the DoD's need for effective treatments for substance use disorders among service members. Emphasize the validated Bayesian MCMC results (85.8% reduction in encoding probability), endorsements from Berridge, Gershman, and Daw, and the open-source platforms (IMPRINT, TOPOLOGIX) as evidence of translational readiness. Highlight the LMIC perspective and potential for global military health impact, but note the need to address US defense relevance explicitly.
Watch Out
Eligibility concern: The DoD Vision Translational Research Award typically requires the applicant to be a US-based institution or individual (US citizen or permanent resident). Eniola is a Nigerian independent researcher without US affiliation, which may disqualify her unless she partners with a US PI or institution. Additionally, the award is likely restricted to US entities for security reasons. Competitive disadvantage: No PhD or MSc, and no prior DoD funding history. The budget ($10K–$100K) is small for translational work, and the deadline (Nov 2026) is far out, but the LMIC angle may not align with DoD priorities.